Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Clorox (CLX) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Consumer StaplesHousehold & Personal ProductsCLX

Latest price · Nov 20, 2026 $106.23 +1.3% on the day · +10.0% over 12 months 52-week range $79.26 – $124.13
Get CLX alerts
Open-market purchases1 insider$1.2M · last 12 months
Insiders selling0last 12 months
Reported sales$0last 12 months
In 15 seconds

Insiders put their own money in: $1.2M of open-market buys. See how similar setups did below.

Past insider buys here: 2 of 2 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • 90-day result for Pierre R. Breber's $400K buy: in on Feb 3, 2027. See the 7- and 30-day results ↓
  • Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Purchase Pierre R. Breber, Director bought 4,000 shares at $100.06 ($400K).

Trade date
Nov 4, 2026
Disclosed to the SEC
Nov 5, 2026
Type
Open-market purchase (code P)

Pierre R. Breber's record since 2025: 2 of 3 past buys beat the S&P 500 over 90 days (small sample).

Read the original SEC filing ↗All CLX insider trades ↓

✦ Read the full investigation of Pierre R. Breber's $400K buy (Nov 5) →

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

CLX insider transactions (Form 4)

Open-market purchases and sales. 67 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 5SEC Pierre R. BreberDirectorPast buys 2/3 beat S&P Buy 4,00022,000 held (+22%) $100.06 $400K +6.2% 72
May 5SEC Pierre R. BreberDirectorPast buys 2/3 beat S&P Buy 5,00018,000 held (+38%) $85.82 $429K +23.8% 72
Nov 24SEC Pierre R. BreberDirectorPast buys 2/3 beat S&P Buy 4,00013,000 held (+44%) $104.13 $417K +2.0% 72

Play with CLX in the Research Lab

Pre-set to CLX's latest insider buy of $10K or more (Nov 5, 2026: Pierre R. Breber, $400K). Tap to change anything.

All tools →

Share price and insider trades

CLX closeInsider buyInsider sale
6080100120140DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-03EEarnings release filed 2026-04-30EEarnings release filed 2026-08-03EEarnings release filed 2026-11-02Bought $400,251 on 2026-11-04 · Pierre R. BreberBought $416,516 on 2025-11-21 · Pierre R. BreberBought $429,124 on 2026-05-05 · Pierre R. Breber
Bought, 12 months$1.2M
Sold, 12 months$0
Insiders buying1
Insiders selling0

Clorox insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $1.2M and 0 sold $0 of CLX stock on the open market; P/E 19.1 vs. a sector median of 21.2.

Setup Odds: how past setups like this did

CLX's latest insider buying (Nov 5, 2026) matched against every similar buy since 2020.

How it works →

1 insider buying no CEO or CFO $250K–$1M stock down 0–20% in 3 months

111 of 221 past setups like this beat the S&P 500 over the next 90 days (50%), against 46% for all insider buys.

50 of 100 similar setups beat the S&P 500beat didn't
−40%−20%0% = S&P+20%+40%
How those 221 cases did vs. the S&P 500 over 90 days. Hover a bar for counts.
Outcome Cloud each dot is one of these 221 past setups; the white ring is CLX's buy, result due in 90 days
Beat the S&P 500 ↑Lagged ↓-50%-25%+0%+25%+50%2020202120222023202420252026BDC 2022-06-21: +31% vs S&P +4%BHVN 2026-03-09: +6% vs S&P +9%ASPN 2023-09-07: +84% vs S&P +3%ADSK 2025-03-24: +10% vs S&P +4%BSM 2026-05-14: +7% vs S&P +4%ASMB 2024-01-19: +29% vs S&P +4%ADP 2026-05-11: +29% vs S&P +5%COLD 2020-12-10: +3% vs S&P +7%OPBK 2022-12-15: -19% vs S&P +0%WY 2022-06-09: -10% vs S&P -0%ACRE 2022-02-25: +5% vs S&P -7%CROX 2024-10-30: -5% vs S&P +5%BMRN 2022-11-02: +37% vs S&P +9%ARKR 2022-12-22: +9% vs S&P +3%ACGL 2026-05-04: +7% vs S&P +4%BRK-B 2026-05-06: +10% vs S&P +5%CODI 2020-06-04: +5% vs S&P +15%CLAR 2024-11-14: +11% vs S&P +2%MBC 2024-08-13: +17% vs S&P +11%BXP 2020-03-12: -10% vs S&P +29%BBW 2022-03-21: +1% vs S&P -17%BXP 2023-03-15: +2% vs S&P +13%TREIX 2023-01-05: +2% vs S&P +8%ADBE 2022-01-10: -15% vs S&P -4%ALLE 2025-11-25: -4% vs S&P +1%COLB 2021-11-29: +13% vs S&P -5%AASP 2026-04-29: +40% vs S&P +4%CE 2022-02-28: +15% vs S&P -5%CME 2024-01-19: +4% vs S&P +4%CME 2020-06-12: -6% vs S&P +10%MBUU 2024-02-23: -16% vs S&P +4%AUR 2025-08-07: -28% vs S&P +7%BX 2022-04-28: -9% vs S&P -6%CDW 2023-05-04: +21% vs S&P +12%BANF 2021-09-14: +23% vs S&P +5%CAI 2026-07-13: +74% vs S&P +4%AFG 2025-02-24: +3% vs S&P -3%CLMT 2023-11-21: +10% vs S&P +11%ATRA 2021-06-15: +15% vs S&P +6%OPBK 2022-08-31: -3% vs S&P +0%AJG 2025-11-03: +3% vs S&P +2%BRO 2023-03-17: +23% vs S&P +13%ALLE 2026-03-12: -11% vs S&P +9%ONEW 2026-02-13: -6% vs S&P +10%BUR 2025-03-10: +4% vs S&P +7%ALKS 2022-11-16: +24% vs S&P +5%CBSH 2022-06-13: +9% vs S&P +9%BHM 2023-03-14: -16% vs S&P +11%CLFD 2025-12-15: -2% vs S&P -2%AGCO 2025-05-07: +21% vs S&P +12%BETA 2026-05-21: +65% vs S&P +4%CDZI 2026-05-28: -8% vs S&P +2%CFR 2022-05-04: -5% vs S&P -4%AESI 2024-10-28: +21% vs S&P +5%OPBK 2022-03-08: -6% vs S&P -1%BPRN 2024-03-18: +3% vs S&P +6%CAG 2021-01-11: +10% vs S&P +9%AMD 2025-02-12: +1% vs S&P -2%COST 2022-06-08: +11% vs S&P -5%DAL 2024-07-15: +20% vs S&P +4%BSTZ 2021-03-23: +18% vs S&P +8%ALTO 2021-05-20: -18% vs S&P +6%AUB 2024-06-10: +22% vs S&P +1%TBLD 2022-01-05: -7% vs S&P -3%CLX 2025-11-24: +18% vs S&P +3%CMG 2021-04-27: +23% vs S&P +6%CRC 2021-12-22: +8% vs S&P -4%ALSN 2025-08-25: -4% vs S&P +3%AMG 2023-03-17: +13% vs S&P +13%C 2020-10-16: +62% vs S&P +9%RBB 2024-03-18: +2% vs S&P +6%AXP 2025-03-11: +18% vs S&P +8%MRNA 2020-02-18: +323% vs S&P -12%CCOI 2022-11-15: +19% vs S&P +4%CVS 2020-05-13: +8% vs S&P +19%AAP 2023-09-14: +3% vs S&P +5%AMSF 2021-08-26: +7% vs S&P +6%BA 2026-05-22: -2% vs S&P +3%CRM 2025-09-10: +8% vs S&P +5%CNNE 2020-03-13: +16% vs S&P +12%AAON 2025-12-15: +9% vs S&P -2%CODI 2022-05-16: +9% vs S&P +7%BSM 2024-08-15: +7% vs S&P +8%BAC 2023-11-03: +19% vs S&P +13%WWD 2021-08-04: +6% vs S&P +6%BTT 2022-01-25: -9% vs S&P -1%CMCL 2026-08-17: -10% vs S&P -2%CKX 2022-09-06: -3% vs S&P +3%AUNA 2026-06-01: +14% vs S&P +2%BPRN 2025-02-12: +6% vs S&P -2%AMH 2022-11-23: +3% vs S&P -0%AUBN 2020-03-12: +34% vs S&P +29%ARCC 2023-05-04: +13% vs S&P +12%GBLI 2021-11-16: +0% vs S&P -6%CRMD 2025-10-27: -34% vs S&P +1%COP 2025-06-17: -3% vs S&P +11%CBSH 2022-07-28: -0% vs S&P -6%AMT 2026-03-12: +8% vs S&P +9%RBB 2022-05-02: +6% vs S&P -0%BKGM 2020-03-09: -10% vs S&P +17%AESI 2025-02-28: -35% vs S&P -0%BWB 2020-09-03: +21% vs S&P +7%BRK-A 2022-07-07: +0% vs S&P -3%ASMB 2024-11-26: -17% vs S&P -0%ARDX 2025-02-26: -22% vs S&P -0%ATR 2022-11-03: +24% vs S&P +11%BG 2026-08-04: -11% vs S&P -2%AN 2022-05-23: +17% vs S&P +7%CHD 2021-03-04: +10% vs S&P +12%BL 2025-08-11: +12% vs S&P +6%CNO 2023-05-19: +7% vs S&P +5%APO 2022-08-31: +19% vs S&P +0%ADI 2022-06-21: +1% vs S&P +4%AMD 2025-05-22: +49% vs S&P +10%AZO 2022-03-21: +3% vs S&P -17%AMT 2025-11-04: -3% vs S&P +3%CRM 2025-03-03: -9% vs S&P +1%CLVT 2025-08-05: -4% vs S&P +9%AYI 2026-04-10: +20% vs S&P +11%ASYS 2022-05-17: +13% vs S&P +5%AIR 2021-07-29: -6% vs S&P +3%BST 2022-02-04: -14% vs S&P -7%BCAT 2021-11-24: -12% vs S&P -8%OPBK 2022-11-08: +6% vs S&P +8%CWH 2022-05-19: +22% vs S&P +10%BUSE 2025-03-12: +8% vs S&P +8%ASPI 2024-07-10: -19% vs S&P +2%BRCC 2025-08-11: -15% vs S&P +6%CLVT 2021-06-15: -5% vs S&P +6%CRSR 2021-04-09: -7% vs S&P +5%CLX 2025-05-09: -6% vs S&P +12%ACNB 2021-07-01: -2% vs S&P +1%BAH 2024-11-25: -23% vs S&P +1%ARKR 2022-06-28: +2% vs S&P -4%AHCO 2021-03-18: -24% vs S&P +8%CME 2022-12-05: +6% vs S&P +2%CLNN 2022-03-30: -24% vs S&P -17%CCI 2020-12-14: +3% vs S&P +9%LEU 2023-03-17: +7% vs S&P +13%CMI 2025-05-16: +22% vs S&P +9%BHR 2022-05-18: +1% vs S&P +10%BRCC 2025-11-19: -43% vs S&P +3%MEGI 2025-01-06: +3% vs S&P -15%ARDX 2025-01-22: -5% vs S&P -13%CRK 2022-08-08: +24% vs S&P -8%BH 2026-06-05: +31% vs S&P +5%XMTR 2024-05-31: +32% vs S&P +6%CMTG 2022-08-18: -1% vs S&P -7%BHVN 2023-08-31: +76% vs S&P +1%DAL 2023-04-27: +40% vs S&P +11%AOSL 2026-03-10: +120% vs S&P +9%CRT 2026-06-26: +38% vs S&P +6%GBCI 2021-07-29: +3% vs S&P +3%COP 2025-11-10: +23% vs S&P +2%BKNG 2022-08-09: -6% vs S&P -7%ASTC 2022-09-07: -23% vs S&P -1%ASPU 2021-10-04: -59% vs S&P +11%CMG 2022-05-20: +32% vs S&P +10%AGO 2022-08-09: +12% vs S&P -7%JKHY 2023-05-30: +7% vs S&P +6%BSTZ 2025-03-14: +9% vs S&P +8%CTOS 2023-05-16: +3% vs S&P +10%BALL 2022-12-07: +5% vs S&P +2%AAACX 2020-07-28: -1% vs S&P +6%CORT 2020-09-01: +81% vs S&P +3%BV 2026-08-06: +10% vs S&P +0%AEYE 2025-11-24: -42% vs S&P +3%ADC 2026-06-08: +0% vs S&P +4%ADBE 2025-01-30: -16% vs S&P -8%ALIT 2021-12-10: -13% vs S&P -9%ADSK 2026-05-29: +17% vs S&P +2%BRC 2022-03-16: +2% vs S&P -14%DAL 2021-12-01: +12% vs S&P -4%AGEN 2024-02-15: -17% vs S&P +6%ALIT 2025-05-20: -31% vs S&P +9%ARDX 2024-11-14: +16% vs S&P +2%ALIT 2022-03-15: -20% vs S&P -12%AWK 2023-11-06: -3% vs S&P +14%ADC 2025-06-13: -0% vs S&P +10%CMTV 2024-08-05: +7% vs S&P +11%OSG 2020-07-13: +1% vs S&P +11%FBK 2023-06-09: -3% vs S&P +4%CCI 2022-02-24: +16% vs S&P -7%ARTV 2026-07-31: -58% vs S&P +3%CBNA 2025-03-03: +12% vs S&P +1%FBK 2025-02-14: -11% vs S&P -3%APTV 2025-12-16: -8% vs S&P -1%CBOE 2020-11-05: +15% vs S&P +9%BAX 2020-04-01: +10% vs S&P +26%ONEW 2023-02-23: -3% vs S&P +3%CSX 2022-05-16: +4% vs S&P +7%ACR 2023-01-04: +8% vs S&P +7%THG 2021-11-30: +15% vs S&P -4%AMG 2026-05-06: +25% vs S&P +5%AXR 2023-10-13: +31% vs S&P +11%BX 2022-03-01: -1% vs S&P -3%AMPY 2023-03-15: +1% vs S&P +13%AES 2021-09-16: -0% vs S&P +6%CFR 2020-02-10: -25% vs S&P -12%BWFG 2023-03-23: -0% vs S&P +11%BOTJ 2021-08-23: +14% vs S&P +5%CARG 2026-03-04: -15% vs S&P +11%BDX 2025-02-10: -27% vs S&P -6%LMND 2026-03-30: +0% vs S&P +16%CRSP 2025-02-28: -16% vs S&P -0%LMNR 2021-09-28: +4% vs S&P +10%BRCC 2023-12-12: +15% vs S&P +11%AGL 2026-03-03: +553% vs S&P +12%BMBL 2022-03-18: +2% vs S&P -18%BX 2022-05-25: -7% vs S&P +4%ACR 2022-09-06: +1% vs S&P +3%BWFG 2022-06-28: -5% vs S&P -4%ARDC 2022-01-27: -8% vs S&P -3%MED 2021-11-10: -11% vs S&P -2%CAG 2023-10-10: +6% vs S&P +10%CAG 2021-07-16: -2% vs S&P +3%CRL 2023-02-24: -11% vs S&P +5%MEGI 2024-03-20: +2% vs S&P +5%C 2020-09-04: +9% vs S&P +7%AOS 2022-02-22: -16% vs S&P -7%BCO 2022-06-14: +1% vs S&P +10%This buy: result due Feb 3, 2027
Median vs. S&P 500+0.0%
Average vs. S&P 500+5.4%
Best+552.8%
Worst-59.3%

History, not a prediction: what happened next in similar past cases, measured from the day the last filing became public. Not investment advice.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

CLX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $417K bought (1 trades)$417KQ4 2025Q1 2026Q2 2026: $429K bought (1 trades)$429KQ2 2026Q3 2026Q4 2026: $400K bought (1 trades)$400KQ4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$400K1—0
Q3 2026—0—0
Q2 2026$429K1—0
Q1 2026—0—0
Q4 2025$417K1—0

Valuation, profit and volume

Watchlist score 52/100
P/E (trailing)19.1Sector median 21.2
Market value$12.87BHousehold & Personal Products
Profit margin9.4%Revenue growth +33.3%
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit+$135KOn all tracked purchases +10.8%

Source: Yahoo Finance, as of Nov 20, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 Clorox insider reported open-market purchases totaling $1.2M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Pierre R. Breber (Director) has the highest Insider Score at 72.

CLX earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 2, 2026 +3.6% None +6.6%S&P -0.2% pending
Aug 3, 2026 -3.2% None +9.6%S&P +3.3% -8.9%
Apr 30, 2026 -8.1% None -8.1%S&P +1.3% +3.3%
Feb 3, 2026 +4.2% None +4.0%S&P -1.3% -2.6%
Nov 3, 2025 -3.4% None -1.8%S&P -1.0% -4.8%
Jul 31, 2025 +1.6% None -2.4%S&P -2.0% -3.0%
May 5, 2025 +0.4% None -2.9%S&P -1.4% -5.7%
Feb 3, 2025 -0.4% None -6.6%S&P -0.0% +0.1%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

CLX short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 77% of volume sold short2026-08-27: 66% of volume sold short2026-08-28: 73% of volume sold short2026-08-31: 65% of volume sold short2026-09-01: 64% of volume sold short2026-09-02: 58% of volume sold short2026-09-03: 53% of volume sold short2026-09-04: 49% of volume sold short2026-09-08: 66% of volume sold short2026-09-09: 69% of volume sold short2026-09-10: 69% of volume sold short2026-09-11: 65% of volume sold short2026-09-14: 65% of volume sold short2026-09-15: 74% of volume sold short2026-09-16: 75% of volume sold short2026-09-17: 65% of volume sold short2026-09-18: 51% of volume sold short2026-09-21: 68% of volume sold short2026-09-22: 59% of volume sold short2026-09-23: 68% of volume sold short2026-09-24: 65% of volume sold short2026-09-25: 68% of volume sold short2026-09-28: 62% of volume sold short2026-09-29: 62% of volume sold short2026-09-30: 64% of volume sold short2026-10-01: 61% of volume sold short2026-10-02: 61% of volume sold short2026-10-05: 66% of volume sold short2026-10-06: 66% of volume sold short2026-10-07: 71% of volume sold short2026-10-08: 55% of volume sold short2026-10-09: 63% of volume sold short2026-10-12: 66% of volume sold short2026-10-13: 67% of volume sold short2026-10-14: 69% of volume sold short2026-10-15: 51% of volume sold short2026-10-16: 70% of volume sold short2026-10-19: 71% of volume sold short2026-10-20: 57% of volume sold short2026-10-21: 63% of volume sold short2026-10-22: 54% of volume sold short2026-10-23: 63% of volume sold short2026-10-26: 59% of volume sold short2026-10-27: 67% of volume sold short2026-10-28: 49% of volume sold short2026-10-29: 63% of volume sold short2026-10-30: 56% of volume sold short2026-11-02: 54% of volume sold short2026-11-03: 64% of volume sold short2026-11-04: 45% of volume sold short2026-11-05: 47% of volume sold short2026-11-06: 54% of volume sold short2026-11-09: 62% of volume sold short2026-11-10: 52% of volume sold short2026-11-11: 49% of volume sold short2026-11-12: 65% of volume sold short2026-11-13: 62% of volume sold short2026-11-16: 59% of volume sold short2026-11-17: 49% of volume sold short2026-11-18: 43% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 43%20-day average: 55%Prior 2 months: 64%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded CLX

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Gilbert Ray Cisneros, Jr.House · D-CA Sold $1,001 - $15,000 May 15, 2026Jun 8, 2026 +18.8%
Gilbert Ray Cisneros, Jr.House · D-CA Bought $1,001 - $15,000 Dec 19, 2025Jan 12, 2026 +11.9%
Gilbert Ray Cisneros, Jr.House · D-CA Sold $1,001 - $15,000 Nov 12, 2025Dec 15, 2025 +5.1%
Lisa C. McClainHouse · R-MI Sold $1,001 - $15,000 Oct 31, 2025Nov 21, 2025 -2.2%
Lisa C. McClainHouse · R-MI Sold $1,001 - $15,000 Oct 30, 2025Nov 21, 2025 -2.2%
Lisa C. McClainHouse · R-MI Bought $1,001 - $15,000 Oct 30, 2025Nov 21, 2025 -2.2%

CLX stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after CLX insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Nov 5, 2026Pierre R. BreberDirector$400K +8.5%+5.2% vs S&Ppendingpending
May 5, 2026Pierre R. BreberDirector$429K +3.5%+1.5% vs S&P+4.1%-0.5% vs S&P+14.1%+9.1% vs S&P
Nov 24, 2025Pierre R. BreberDirector$417K +0.7%-1.0% vs S&P-7.1%-10.6% vs S&P+21.3%+19.0% vs S&P

Insiders at Clorox

InsiderBoughtSoldLast filingPast buys beat S&PScore
Pierre R. BreberDirector $1.2M — Nov 5, 2026 2 of 3 72
Linda J. RendleCEO — — Oct 7, 2026 — —
Angela C. HiltGeneral Counsel — — Oct 7, 2026 — —
Kirsten MarrinerEvp - Chief Admin Officer — — Oct 7, 2026 — —
Chris T. HyderCOO — — Oct 7, 2026 — —
Luc BelletCFO — — Oct 7, 2026 — —
Laurene E. PeckVp - Cao & Corp Controller — — Oct 7, 2026 — —
Nina BartonEvp-Chief Growth & Strategy Of — — Oct 7, 2026 — —
Stacey GrierEvp - Executive Chief Of Staff — — Mar 17, 2026 — —
Eric H. ReynoldsCOO — — Dec 16, 2025 — —

Board links: companies that share insiders with CLX

Directors and executives who filed Form 4s for CLX and another company in the last 12 months.

See the map →
  • LUVSouthwest Airlines Pierre R. Breber Director here · Director at LUV · latest filing Nov 5, 2026

Insider activity at other Consumer Staples companies

Same sector, ranked by insider buying in the last 90 days.

  • COURCoursera, Inc.$42.8M bought
  • LRNStride, Inc.$39.6M bought
  • COE51Talk Online Education Group$32.3M bought
  • PEPPepsiCo$23.7M bought
  • DOLEDole plc$21.6M bought
  • SUJASUJA LIFE, INC.$20.3M bought

CLX stock: common questions

Are Clorox insiders buying CLX stock?

In the past 12 months, 1 insider reported open-market purchases of CLX worth $1.2M. The latest was Director Pierre R Breber bought $400K of CLX at $100.06 — raises the stake by 22%.

Are Clorox insiders selling CLX stock?

No. No Clorox insider reported an open-market sale of CLX in the past 12 months.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CLX's P/E ratio?

CLX trades at about 19.1 times trailing earnings, compared with a median of 21.2 for the Consumer Staples sector.

What is CLX's 52-week range?

Over the past year CLX has traded between $79.26 and $124.13. It last closed at $106.23 on Nov 20, 2026.